Crossmark

Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella

Crossref DOI link: https://doi.org/10.1007/s40273-023-01252-z

Published Online: 2023-02-21

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Doggen, Kris

van Hoek, Albert Jan

Luyten, Jeroen https://orcid.org/0000-0001-6398-4025
License Information

Text and Data Mining valid from 2023-02-21

Version of Record valid from 2023-02-21
More Information

Article History

Accepted: 9 February 2023

First Online: 21 February 2023

Declarations

:

: This study received no funding.

: JL participated in workshops on economic evaluation of vaccines (for Pfizer and MSD) and medically assisted reproduction (Merck), for which his employer (KU Leuven) has received financial compensation. All disclosures were unrelated to the present work. AJvH and KD have no conflicts of interest to disclose.

: The data extracted from the publications identified by the systematic review are available as Supporting Information.

: Conception or design of the work: JL, AJvH, KD. Data collection: KD. Data analysis and interpretation: KD, JL, AJvH. Drafting the article: KD, JL, AJvH. Critical revision of the article: JL, AJvH. Final approval of the version to be published: KD, JL, AJvH.

Document is current

Any future updates will be listed below